TIDMAMS

RNS Number : 2146K

Advanced Medical Solutions Grp PLC

15 April 2015

15 April 2015

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Directors' Shareholdings

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, announces that on 15 April 2015, the Board, following a recommendation from the Remuneration Committee, granted new share options to the following Directors under the Advanced Medical Solutions Deferred Annual Bonus Plan (the '2014 DAB').

This award is in respect of the part of their bonus that the Directors are compulsorily required to defer for the 2014 financial year. These options vest at the end of three years.

 
         Director            Total options under all schemes prior to grant   Options granted   Resultant holding 
--------------------------  -----------------------------------------------  ----------------  ------------------ 
 Chris Meredith 
  Chief Executive Officer                                           930,300            27,377             957,677 
--------------------------  -----------------------------------------------  ----------------  ------------------ 
 Mary Tavener 
  Group Finance Director                                            660,312            19,331             679,643 
--------------------------  -----------------------------------------------  ----------------  ------------------

- Ends -

For further information, please visit www.admedsol.com or contact:

 
Advanced Medical Solutions Group plc 
 Chris Meredith, Chief Executive Officer 
 Mary Tavener, Group Finance Director                                   +44 (0) 1606 545508 
Consilium Strategic Communications                                     +44 (0) 20 3709 5700 
 Mary-Jane Elliot / Jonathan Birt / Matthew Neal / Ivar Milligan    AMS@consilium-comms.com 
Investec Bank plc (NOMAD & Broker) 
 Gary Clarence / Daniel Adams / Patrick Robb                           +44 (0) 20 7597 5970

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 472 employees. For more information please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFIRSFISLIE

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.